» Articles » PMID: 29392642

Impairment of Acquired Color Vision in Multiple Sclerosis: an Early Diagnostic Sign Linked to the Greatness of Disease

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 2018 Feb 3
PMID 29392642
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the type and degree of both red-green and blue-yellow color vision deficiencies of Calabrian males affected by multiple sclerosis.

Material: Eighty Calabrian male patients were enrolled (age range 18-70 years; mean age 40.6 ± 12.4 years) showing a disease duration mean of 10.6 ± 8.2 years (range = 0.5-46 years) coming from the Institute of Neurology, Magna Graecia University, Catanzaro. Optic neuritis present in the medical histories of the 21 patients does not influence color vision. Excluding seven colorblind subjects and one affected by a bilateral maculopathy, the analyzed sample group was 72. Seventy controls were matched for age and sex.

Method: An ophthalmologist examined all patients and controls in order to rule out diabetic retinopathy, cataracts, senile maculopathy, or ocular fundus' anomalies. The Ishihara test identified the colorblind patients. The City University Test screened for people with abnormal color vision by grading the severity of color vision deficiency. The second part of the City University Test as well as the Farnsworth Test confirmed both the color vision deficiency type and degree.

Results: Fifty-one percentage (37/72) of the patients showing a color vision deficiency were subdivided into two subgroups: subgroup one showed red-green deficiency (57%, 21/37); subgroup two showed a coupled red-green and blue-yellow deficiency (43%, 16/37). Furthermore, we found two distinct curves showing a groove within the first 10 years of the disease. Both monocular and binocular analyses allowed us to identify the patients showing the monocular color vision deficiency, but they were well compensated by binocular vision.

Conclusion: We think that the majority of the patients with the red-green deficiency will develop the coupled red-green and blue-yellow deficiency in the latter years of multiple sclerosis.

Citing Articles

Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy.

de Muijnck C, Haer-Wigman L, van Everdingen J, Lushchyk T, Heutinck P, van Dooren M Sci Rep. 2024; 14(1):22956.

PMID: 39363032 PMC: 11450207. DOI: 10.1038/s41598-024-74364-x.


Dental Color-Matching Ability: Comparison between Visual Determination and Technology.

Menini M, Rivolta L, Manauta J, Nuvina M, Kovacs-Vajna Z, Pesce P Dent J (Basel). 2024; 12(9).

PMID: 39329850 PMC: 11431472. DOI: 10.3390/dj12090284.


The prevalence of red-green color vision deficiency and its related factors in an elderly population above 60 years of age.

Hashemi H, Shahidi A, Hashemi A, Jamali A, Mortazavi A, Khabazkhoob M Int J Ophthalmol. 2023; 16(9):1535-1541.

PMID: 37724279 PMC: 10475627. DOI: 10.18240/ijo.2023.09.22.


The impacts of abnormal color vision on people's life: an integrative review.

Stoianov M, de Oliveira M, Dos Santos Ribeiro Silva M, Ferreira M, de Oliveira Marques I, Gualtieri M Qual Life Res. 2018; 28(4):855-862.

PMID: 30443703 DOI: 10.1007/s11136-018-2030-1.

References
1.
Tagarelli A, Piro A, Tagarelli G, Zinno F . Color-blindness in Calabria (Southern Italy): A north-south decreasing trend. Am J Hum Biol. 2001; 12(1):17-24. DOI: 10.1002/(SICI)1520-6300(200001/02)12:1<17::AID-AJHB3>3.0.CO;2-D. View

2.
WALLS G . How good is the H-R-R test for color blindness. Am J Optom Arch Am Acad Optom. 1959; 36(4):169-93. DOI: 10.1097/00006324-195904000-00001. View

3.
Lyon M . Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature. 1961; 190:372-3. DOI: 10.1038/190372a0. View

4.
Cole B, Lian K, Lakkis C . The new Richmond HRR pseudoisochromatic test for colour vision is better than the Ishihara test. Clin Exp Optom. 2006; 89(2):73-80. DOI: 10.1111/j.1444-0938.2006.00015.x. View

5.
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vecsei L . The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006; 13(7):700-22. DOI: 10.1111/j.1468-1331.2006.01342.x. View